Port-only 4-Arms Robotic Segmentectomy Under Artificial Pneumothorax.
10.3779/j.issn.1009-3419.2022.101.52
- Author:
Yulong CHEN
1
;
Hui CHEN
1
;
Feng XU
1
;
Bingsheng SUN
1
;
Jian YOU
1
Author Information
1. Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Lung Cancer Center,
Tianjin Cancer Hospital Airport Hospital National Clinical Research Center for Cancer, Tianjin 300060, China.
- Publication Type:Journal Article
- Keywords:
Artificial pneumothorax;
Lung neoplasms;
Port-only;
Robot assisted thoracic surgery;
Segmentectomy
- MeSH:
Humans;
Pneumothorax, Artificial;
Robotic Surgical Procedures;
Pneumonectomy;
Lung Neoplasms/surgery*;
Robotics
- From:
Chinese Journal of Lung Cancer
2022;25(11):797-802
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND:At present, robotic surgery is widely used in thoracic surgery, which has higher maneuverability, precision, and stability, especially for small space complex operations and reconstructive surgery. The advantages of robotic lung segment resection under full orifice artificial pneumothorax are obvious.
METHODS:Based on a large number of clinical practices, we established a set of surgical methods for 4-arm robotic lung segment resection under a port-only artificial pneumothorax. 98 cases of robotic lung segment resection were performed with this method from January 2019 to August 2022. The clinical experience was summarized.
RESULTS:Robotic lung segment resection under port-only artificial pneumothorax has obvious advantages in the anatomy of lung segment vessels and bronchi. It is characterized by less bleeding, shorter operation time, adequate exposure, and flexible operation.
CONCLUSIONS:This surgical model we propose optimizes the operation mode and technique of lung segment resection, makes each step procedural, reduces collateral damage, and is easy to learn and master, which is believed to cure more lung cancer patients with less trauma.